BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 37285657)

  • 1. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
    Gao H; Cheng M; Liu H; Ding L
    J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects.
    Gao H; Li J; Chen X; Sun Z; Cui G; Cheng M; Ding L
    Front Pharmacol; 2022; 13():1064364. PubMed ID: 36588683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study.
    Chu NN; Huang K; Que LL; Ding Y; Gu XH; Zhang L; Wang JK; Chen XP; Sun ZG; He Q
    Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):509-521. PubMed ID: 35429285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, Mass Balance, Tissue Distribution and Metabolism of [
    Gao H; Yang C; Hu W; Ding J; Diao X; Zheng Y; Shu C; Ding L
    Curr Drug Metab; 2023; 24(11):770-779. PubMed ID: 38073103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: A clinical pharmacokinetics and excretion study.
    Li Y; Zhan H; Fan Y; Zhang J; Cao G; Yu J; Chen Y; Guo B
    Drug Test Anal; 2019 Jul; 11(7):1035-1047. PubMed ID: 30821115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of cefaclor in human plasma using SIL-IS LC-ESI-MS/MS for pharmacokinetics study in healthy Chinese volunteers.
    Chen X; Liu G; Wang C; Liu R; Wang M; Huang Y; Shen J; Jia Y
    Biomed Chromatogr; 2023 Aug; 37(8):e5638. PubMed ID: 37002731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Tissue Distribution of Nasal Spray of a Novel Muscarinic Receptor Blocker, 101BHG-D01, in Dogs and Rats.
    Wei H; Wu L; Jia Y; Shen J; Li Y; Sun P; Xie Q; Chen X; Xie Y; Wang Y; Zhao Z
    Curr Drug Metab; 2022 Dec; 23(13):1080-8. PubMed ID: 36464876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of a novel nonfluorinated quinolone, nemonoxacin, in human feces and its glucuronide conjugate in human urine and feces by high-performance liquid chromatography-triple quadrupole mass spectrometry.
    He G; Guo B; Yu J; Zhang J; Wu X; Cao G; Shi Y; Tsai CY
    Biomed Chromatogr; 2015 May; 29(5):739-48. PubMed ID: 25322721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma.
    Lin L; Gao Z; Chen X; Zhong D
    J Pharm Biomed Anal; 2013 Dec; 86():49-55. PubMed ID: 23973791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
    Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
    J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and excretion study of sophoricoside and its metabolite in rats by liquid chromatography tandem mass spectrometry.
    Zhi X; Sheng N; Yuan L; Zhang Z; Jia P; Zhang X; Zhang L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():154-62. PubMed ID: 24342508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study.
    Ni XJ; Wang ZZ; Shang DW; Zhang M; Hu JQ; Qiu C; Wen YG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():247-52. PubMed ID: 24835512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of sixteen antibiotics and four
    Li ZH; Hu XJ; Lu YF; Xie LN; Zhu Y
    Se Pu; 2023 May; 41(5):397-408. PubMed ID: 37087605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of imperatorin and its metabolite xanthotoxol in rat plasma and urine by LC-MS/MS and its application to pharmacokinetic studies.
    Ngo L; Tran P; Ham SH; Cho JH; Cho HY; Lee YB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():30-38. PubMed ID: 28064067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of Olanzapine and Fluoxetine in human plasma by LC-MS/MS: its pharmacokinetic application.
    Bonde SL; Bhadane RP; Gaikwad A; Gavali SR; Katale DU; Narendiran AS
    J Pharm Biomed Anal; 2014 Mar; 90():64-71. PubMed ID: 24334191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of samples stabilization strategy and LC-MS/MS method for simultaneous determination of clevidipine and its primary metabolite in human plasma: Application to clinical pharmacokinetic study in Chinese healthy volunteers.
    Zhang Y; Zhao S; Zhou H; Ding L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1161():122448. PubMed ID: 33246284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Liquid Chromatography Tandem Mass Spectrometry Method for the Simultaneous Estimation of the Dopamine Receptor Antagonist LE300 and Its N-methyl Metabolite in Plasma: Application to a Pharmacokinetic Study.
    Hefnawy MM; Attwa MW; Alzamil AA; El-Gendy MA; El-Azab AS; Jardan YAB; El-Gamal AA
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly sensitive determination of three kinds of amanitins in urine and plasma by ultra performance liquid chromatography-triple quadrupole mass spectrometry coupled with immunoaffinity column clean-up].
    Zhang X; Cai X; Zhang X; Li R; Zhao Y
    Se Pu; 2022 May; 40(5):443-451. PubMed ID: 35478003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
    Jemal M; Schuster A; Whigan DB
    Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.